| 000 | 01526 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511215938.0 | ||
| 264 | 0 | _c19910517 | |
| 008 | 199105s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/0145-2126(91)90093-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHatfill, S J | |
| 245 | 0 | 0 |
_aInduction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites. _h[electronic resource] |
| 260 |
_bLeukemia research _c1991 |
||
| 300 |
_a129-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xmetabolism |
| 650 | 0 | 4 |
_aAntigens, Surface _xmetabolism |
| 650 | 0 | 4 | _aAntineoplastic Agents |
| 650 | 0 | 4 |
_aBlast Crisis _xenzymology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xenzymology |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xmetabolism |
| 650 | 0 | 4 |
_aNaphthol AS D Esterase _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aThalidomide _xmetabolism |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 700 | 1 | _aFester, E D | |
| 700 | 1 | _ade Beer, D P | |
| 700 | 1 | _aBohm, L | |
| 773 | 0 |
_tLeukemia research _gvol. 15 _gno. 2-3 _gp. 129-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0145-2126(91)90093-9 _zAvailable from publisher's website |
| 999 |
_c2023085 _d2023085 |
||